Form Health Unveils New Program to Prevent the Transition from Overweight to Obesity – MedCity News
Form Health launched a new program for people who are overweight that includes meetings with a registered dietitian and a personalized care plan.
Related Articles
Best of JAC-Antimicrobial Resistance 2024
As we usher in the new year, the Editor-in-Chief of BSAC’s JAC-Antimicrobial Resistance would like to warmly thank all authors and expert peer reviewers wh
Patient Information: Essential Tremor
This JAMA Patient Page describes essential tremor, its symptoms, risk factors, diagnosis, and treatment.
Perinatal Smoking Patterns From Preconception to 1-Year Post Partum
This cohort study assesses rates of maternal smoking in the United States during the perinatal period overall and by age, race and ethnicity, insurance type,…
Estimating the need for diabetic retinopathy services in north India: evidence from a population-based survey in the catchment population of an eye care provider in central Uttar Pradesh
Objective The aim of this study was to assess the prevalence of diabetic retinopathy (DR) and retina screening coverage among people with diabetes in the…
Welcome Back to The Respiratory Report
In this summary, we highlight the latest issue of our pulmonology research quarterly newsletter powered by the American Lung Association Research Institute.
MedRhythms earns Medicare win for stroke gait impairment treatment
MedRhythms announced that it received a final pricing determination from CMS for its InTandem rehabilitation system.
Hybrid and Virtual Care: Interest Outstrips Infrastructure
NEJM Catalyst Insights Council members worldwide say hybrid care delivery improves overall care quality.
Biden names GLP-1 drugs Ozempic, Wegovy for price negotiation program
The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs Ozempic, Wegovy and Rybelsus, for the second round of drug price negotiations,…
Psychological profiles associated with mental, cognitive and brain health in middle-aged and older adults
Nature Mental Health – This cross-sectional study in two independent middle-aged and aged cohorts investigates whether psychological characteristics associated with varying dementia risk aggregate…
Online marketing for compounded GLP-1 drugs overstates benefits and underplays risks
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, contraindications.
